No Result
View All Result
  • Login
Monday, May 16, 2022
Afternoon Voice
SUBSCRIBE
  • Home
  • Top News
  • City News
  • Nation
  • World
  • Entertainment
    • Bollywood
    • Hollywood
  • Sports
    • Cricket
    • Hockey
    • Tennis
    • Football
    • Badminton
  • Editorial
  • Opinion
    • Column
    • Diary
    • Letters
  • Epaper
  • More
    • Editor’s Pick
    • Featured
    • Lifestyle
    • Different Strokes
    • Multimedia
    • Sci-Tech
    • Politics
No Result
View All Result
  • Home
  • Top News
  • City News
  • Nation
  • World
  • Entertainment
    • Bollywood
    • Hollywood
  • Sports
    • Cricket
    • Hockey
    • Tennis
    • Football
    • Badminton
  • Editorial
  • Opinion
    • Column
    • Diary
    • Letters
  • Epaper
  • More
    • Editor’s Pick
    • Featured
    • Lifestyle
    • Different Strokes
    • Multimedia
    • Sci-Tech
    • Politics
No Result
View All Result
Afternoon Voice
No Result
View All Result
  • Home
  • Top News
  • City News
  • Nation
  • World
  • Entertainment
  • Sports
  • Editorial
  • Opinion
  • Epaper
  • More

Home > Uncategorized > Lupin Q4 net up 35pc at Rs. 553 cr; FY14 profit at Rs. 1,836 cr

Lupin Q4 net up 35pc at Rs. 553 cr; FY14 profit at Rs. 1,836 cr

afternoonvoice@gmail.com' by Afternoon Voice
May 7, 2014
in Uncategorized
A A
0

Drug major Lupin on Wednesday posted 35.5 percent rise in consolidated net profit at Rs 553 crore for the fourth quarter ended March 31, 2013-14, on the back of robust sales in various markets including the US, Europe and South Africa.

The company had posted net profit of Rs 408.08 crore in the January-March quarter of the 2012-13 fiscal.

Net sales of the company rose to Rs 3,051.55 crore in Q4, 2013-14, from Rs 2,537.35 crore in the year-ago period, Lupin Ltd said in a statement.

For the entire 2013-14, it posted consolidated net profit of Rs 1,836.37 crore, up 39.7 percent, as compared to Rs 1,314.16 crore in the 2012-13 fiscal.

Lupin’s consolidated net sales last fiscal rose to Rs 11,086.64 crore, from Rs 9,461.63 crore in 2012-13.

“We have had another remarkable year fuelled by strong growth in key markets like the US, Europe, South Africa and in our API business,” Lupin Ltd Managing Director, Nilesh Gupta said.

Importantly, the company was able to improve operational efficiencies substantially, he added.

“The year also marked our entry into high growth markets like Mexico and acquiring technology research capabilities that would help us address niche segments like complex injectables and inhalation,” Gupta said.

The company’s US and Europe formulation sales (including IP) grew by 28 percent to Rs 1,549.4 crore during the fourth quarter, as against Rs 1,212.3 crore in the same period of previous fiscal, contributing 51 percent to overall sales.

For the year ended March 31, 2014, the company’s US and Europe formulation sales grew by 29 percent to Rs 5,180.5 crore as against Rs 4,005.1 crore in 2012-13, contributing 47 percent to overall sales.

The company said its domestic business grew by 2 percent in Q4, 2013-14, recording net revenues of Rs 576.3 crore, as compared to Rs 565.9 crore in the year-ago period.

For 2013-14, the domestic formulations business grew by 5 percent recording revenues of Rs 2,479.5 crore, as compared to Rs 2,364.4 crore in 2012-13.

The company’s South African subsidiary, Pharma Dynamics clocked in revenues of Rs 380 crore in 2013-14 as compared to Rs 3,21 crore in 2012-13, a growth of 18 percent.

Lupin’s Japanese business clocked net sales of Rs 1,295.5 crore during 2013-14 and contributed 11 percent to the company’s consolidated revenues.

The company said its API sales grew by 17 percent to Rs 1,114 crore during 2013-14 contributing to 10 percent to the Lupin’s consolidated revenues.

The company’s board, which met today, proposed a final dividend of 150 percent, making it a total dividend of 300 percent for FY 2013-14.

afternoonvoice@gmail.com'

Afternoon Voice

Recommended For You

p chidambaram, chidambaram, congress, Jawaharlal Nehru, Narendra Modi
Uncategorized

Attempt to distort history, Nehru intervened in Goa at right time: Chidambaram on PM’s criticism

February 11, 2022
ks sethumadhavan, director, south indian, filmmaker, sethumadhavan
Uncategorized

Legendary South Indian director K S Sethumadhavan passes away

February 9, 2022
japanese, japan pm, shinzo abe, shinzo
Uncategorized

Ex-Japan PM says a Chinese military “adventure” could be “suicidal”

February 9, 2022
tayyip erdogan, erdogan, Alevi, Alevi community, AK Party
Uncategorized

Tayyip Erdogan faces uphill bid to woo Turkey’s large Alevi minority

February 9, 2022
aghanistan, afghan, violence, violence against women, taliban
Uncategorized

UN raises issue of violence against women, girls in Afghanistan

February 9, 2022
australia, covid-19, covid restrictions, australia travel
Uncategorized

Australia announces easing of travel restrictions from December 1

February 9, 2022
ADVERTISEMENT

LATEST NEWS

Each member of a cooperative housing society demands dignity

Each member of a cooperative housing society demands dignity

May 16, 2022
sanjay pandey, housing society, society, housing, pandey

Mumbai CP announces dedicated police stations for housing society complaints

May 16, 2022
chardham yatra, heart attack, chardham

Chardham Yatra: ‘Heart attack, mountain sickness’ cause 39 deaths in 2 weeks

May 16, 2022
brahmin, dalit, maratha, maratha flag, ketaki chitale, maratha

Maharashtra politics got propagated as Brahmins Vs Maratha and Dalits

May 15, 2022
andrew symonds, car crash, australian cricketer, cricketer

Former Australia all-rounder Andrew Symonds dies in a car crash

May 15, 2022
ketaki chitale, chitale, pawar, sharad pawar, ncp, raj thackeray, devendra fadnavis, kalamboli, navi mumbai police, police, derogatory statement

Is Ketaki Chitale’s Brahmanical patriarchy getting her in trouble?

May 15, 2022
ADVERTISEMENT

EDITOR TWEETS

Tweets by @vaidehisachin
Afternoon Voice

© 2022 Newsmakers Publications Pvt. Ltd. | All rights reserved.

Important Links

  • Disclaimer
  • Privacy Policy
  • About Us
  • Contact Us
  • Support Parallel Media

Follow Us

No Result
View All Result
  • Home
  • Top News
  • City News
  • Nation
  • World
  • Entertainment
    • Bollywood
    • Hollywood
  • Sports
    • Cricket
    • Hockey
    • Tennis
    • Football
    • Badminton
  • Editorial
  • Opinion
    • Column
    • Diary
    • Letters
  • Epaper
  • More
    • Editor’s Pick
    • Featured
    • Lifestyle
    • Different Strokes
    • Multimedia
    • Sci-Tech
    • Politics

© 2022 Newsmakers Publications Pvt. Ltd. | All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?